- Home
- SBLK vs BCRX Comparison
SBLK vs BCRX Comparison
Compare SBLK & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBLK
- BCRX
- Stock Information
- Founded
- SBLK 2006
- BCRX 1986
- Country
- SBLK Greece
- BCRX United States
- Employees
- SBLK N/A
- BCRX N/A
- Industry
- SBLK Marine Transportation
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SBLK Consumer Discretionary
- BCRX Health Care
- Exchange
- SBLK Nasdaq
- BCRX Nasdaq
- Market Cap
- SBLK 1.9B
- BCRX 1.7B
- IPO Year
- SBLK N/A
- BCRX 1994
- Fundamental
- Price
- SBLK $12.84
- BCRX $6.85
- Analyst Decision
- SBLK Strong Buy
- BCRX Buy
- Analyst Count
- SBLK 3
- BCRX 6
- Target Price
- SBLK $22.67
- BCRX $15.67
- AVG Volume (30 Days)
- SBLK 2.1M
- BCRX 2.9M
- Earning Date
- SBLK 05-21-2025
- BCRX 05-05-2025
- Dividend Yield
- SBLK 15.06%
- BCRX N/A
- EPS Growth
- SBLK 60.00
- BCRX N/A
- EPS
- SBLK 2.80
- BCRX N/A
- Revenue
- SBLK $1,265,458,000.00
- BCRX $450,712,000.00
- Revenue This Year
- SBLK N/A
- BCRX $27.66
- Revenue Next Year
- SBLK $18.23
- BCRX $13.59
- P/E Ratio
- SBLK $5.59
- BCRX N/A
- Revenue Growth
- SBLK 33.31
- BCRX 36.00
- 52 Week Low
- SBLK $14.20
- BCRX $4.03
- 52 Week High
- SBLK $27.47
- BCRX $9.50
- Technical
- Relative Strength Index (RSI)
- SBLK 23.83
- BCRX 32.78
- Support Level
- SBLK $15.24
- BCRX $7.15
- Resistance Level
- SBLK $15.81
- BCRX $7.93
- Average True Range (ATR)
- SBLK 0.46
- BCRX 0.25
- MACD
- SBLK -0.33
- BCRX -0.06
- Stochastic Oscillator
- SBLK 0.97
- BCRX 0.00
About SBLK Star Bulk Carriers Corp.
Star Bulk Carriers Corp provides seaborne transportation solutions in the dry bulk sector. The company owns and operates dry bulk carrier vessels, which are used to transport bulk, such as iron ore, coal, grains, bauxite, fertilizers, and steel products. It owns a fleet of vessels that consists of Newcastlemax, Capesize, Post Panamax, Kamsarmax, Panamax, Ultramax, and Supramax. It generates revenues through the voyages it carries out.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.